Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.290
+0.010 (0.78%)
At close: Feb 26, 2026, 4:00 PM EST
1.300
+0.010 (0.78%)
After-hours: Feb 26, 2026, 4:26 PM EST
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $79.27 million as of February 26, 2026. Its market cap has decreased by -57.57% in one year.
Market Cap
79.27M
Enterprise Value
-102.36M
1-Year Change
-57.57%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $79.27M, a decrease of -89.25%. That is a compound annual growth rate of -32.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 78.66M | 4.92% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 81.24M |
| Gain Therapeutics | 80.39M |
| Pelthos Therapeutics | 78.99M |
| PolyPid | 77.18M |
| TuHURA Biosciences | 75.29M |
| Seres Therapeutics | 73.82M |
| MediciNova | 73.34M |
| eXoZymes | 72.66M |